Guru Ramanathan appointed to the Board of Nemysis

Nemysis Limited, a Dublin-based healthcare and pharmaceutical company, announced that it has appointed Guru Ramanathan to its Board of Directors.  

Guru Ramanathan, Senior Executive specialized in Global Healthcare innovation management and commercialization, brings with him over 30 years of leadership experience and knowledge worldwide, focused on customer-centric R&D, strategic business planning and pre- and post-marketing activities.

Prior to this role, Guru served as Chief Innovation Officer at General Nutrition Corporation and, before that, he was Sr. Director of Scientific Affairs at Royal Numico (now Nutricia-Danone).

In his new role, Guru will play a key role in meeting the company’s significant growth goals, as well as building on the firm’s impressive role in tackling iron deficiency/anemia and gluten intolerance.

“I cannot think of anyone better than Guru to join our Board into the next phase, so I am delighted that all Board Members and Shareholders agreed to appoint him as a new Member of the Board of Directors. His ability to think strategically has already ensured him a pivotal role within the healthcare arena. His vision for how our new gluten intolerance products can be developed in the international market will support our next chapter of innovation and growth for Nemysis Ltd,” said Danilo Casadei Massari, Chairman of the Board of Directors.

Guru stated: “I am truly honoured to join the Directors of Nemysis. I am impressed with the entrepreneurial spirit that this company brings and look forward to a number of exciting developments in the months to come. It is a privilege to work with a group so committed to building a successful and innovative company.”

Guru holds an MBA in General Management with special emphasis on global business practices, from Duke University, and a PhD in Healthcare Innovation Management from Tufts University.

Nemysis Ltd is focussed on nutritional and pharmaceutical solutions that can protect against some of the negative consequences of nutrient deficiency, nutrient intolerances and sensitivities, paying particular attention to the need to safeguard the human microbiome. 

Website | + posts

HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.

What's your take on this post ? Comment: